Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeabrdn European Logistics Income plc(c) Name of the party to the offer with which exempt principal trader is...
A director at Capital One Financial Corp sold 8,656 shares at 144.036USD and the significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
>13% organic revenue growth, fewer working days but perm recovering - Brunel reported 13% organic revenue growth in Q1, with EBIT down 9% at €14.3m, compared with our forecast of €13.7m. Organic EBIT growth was 14% but two fewer working days in Germany and one less working day in the Netherlands impacted EBIT growth by 24%, some €2m. Revenue growth was driven by growth in renewable energy (11% of group), conventional energy (40%), mining (10%) and life science (6%). P...
Form 8.5 (EPT/RI) - Renalytix plc FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeRenalytix plc(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Joint Broker to Renal...
>A good Q1 in terms of the EBITDA margin, buoyed by the mix - Yesterday evening, UMG published Q1 results that came in a shade above our expectations with adjusted EBITDA of € 591m vs our forecast of € 573m, i.e. a 150bp improvement in the margin, buoyed by a favourable mix and robust growth in publishing. Growth at constant forex in the paid streaming activity (+12.3%) came in slightly below our forecast of 13.5% confirming a relatively dynamic quarter that remains u...
In our view, the sharp negative market reaction was triggered by subdued trends in China and April trends which were slightly below the Q1 top-line performance (+6% FX-n), on top of another tough comparison base (Q2 2023: +20% FX-n). Whilst FY24 outlook was reiterated, management's relatively cauti
Egetis reported Q1 2024 results with an operating loss of SEK (68.6m) and a cash position of SEK 251.7m. In the pipeline, the most important update has been to the status of the critical US phase 3 trial, where the company reported that 13/16 patients have been recruited, whereof 6 patients have co
A director at Chocoladefabriken Lindt & Sprungli AG sold 1,650 shares at 10,495.321CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
A director at Conmed Corp bought 3,000 shares at 68.300USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
At the post-FOMC press conference, what is not said is sometimes more significant than what is said. Jerome Powell has repeatedly been asked about the possibility of resuming rate hikes in order to curb inflation. Each time, he has refrained from considering this option. The US economy is growing at a solid, albeit not accelerating, pace. There are an increasing number of signs that employment conditions are moderating. To date, the Fed considers its monetary policy to be restric...
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med InterMail A/S' aktier Selskabsmeddelelse nr. 21 2023/243. maj 2024 Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med InterMail A/S' aktier InterMail A/S har dags dato modtaget meddelelser om transaktioner med selskabets aktier foretaget af ledende medarbejdere og/eller personer/selskaber der er nærtstående til disse. Der henvises til de vedhæftede filer. Venlig hilsen InterMail A/S Yderligere oplysninger: John Dueholm, BestyrelsesformandTelefon: 31 24 49 31E-mail: ...
Shurgard 1Q24 results came slightly below our estimates as increased RE-taxes hit 1Q harder than expected. Also 4.0% lfl operating revenue growth came below our 4.7% expectation. The EPRA Earnings amounted to EUR 34.2m, +12.6% yoy vs. our expectation of 35.3m. Guidance FY24 excludes the Lok'nStore bid and indicates a 7.5% revenue growth in line with our previous estimates. The balance sheet offers ample headroom with LTV at 14.6%. The results still show a resilient operational performance, impa...
NEWS SUMMARY: ACERINOX, IBERDROLA. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 1Q’24 results to be released over the coming days in Spain. Doubts on the market despite an accommodating Fed With the exceptions of the IBEX and FTSE 100, it was a session of losses on European stock markets with strong sector dispersion, and where falling sovereign debt yields reeled in part o...
Since the start of year, UCB has rallied 53.5% from €79.2 to €121.0+ thanks to positive momentum on Bimzelx' commercial uptake. UCB has entered a new growth phase as it turns the page on the loss of exclusivity of several of its mature assets. The new chapter will focus strongly on five growth drivers: Bimzelx, Rystiggo, Zilbrysq, Fintepla and Evenity. Jointly, these assets could deliver significant topline growth and margin improvements in the coming years – we updated our model and raised our ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.